NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics

Archives of Internal Medicine

Volumn 158, Issue 10, 1998, Pages 1108-1112

  Heerdink, Eibert R ^a   Leufkens, Hubert G ^a   Herings, Ron M C ^a   Ottervanger, Jan P ^b,c   Stricker, Bruno H C ^b   Bakker, Albert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RESPONSE; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SODIUM ABSORPTION;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIURETICS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RISK; RISK FACTORS;

EID: 0032565606     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.10.1108     Document Type: Article

References (28)

1. Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu Rev Pharmacol Toxicol. 1993;32:435-465.
2. Furst DE. Are there differences among nonsteroidal antiinflammatory drugs? Arthritis Rheum. 1994;37:1-9.
3. Brater DC, Anderson SA, Brown-Cartwright D, Toto RD. Effects of NSAIDs on renal function in patients with renal insufficiency and in cirrhotics. Am J Kidney Dis. 1987;8:351-355.
4. Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. Ann Intern Med. 1990;112:559-560.
5. Cannon PJ. Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1986;81(suppl 2B):123-132.
6. Whelton A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med. 1990;112:568-576.
7. Simon LS, Basch CM, Young DY, Robinson DR. Effects of naproxen on renal function in older patients with mild to moderate renal dysfunction. Br J Rheumatol. 1992;31:183-168.
8. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984;310:563-572.
9. Schlondorff D. Renal complications of non-steroidal anti-inflammatory drugs. Kidney Int. 1993;44:643-653.
10. Johnson AG, Seideman P, Day PO. Adverse drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs). Drug Saf. 1993;8:99-127.
11. Laiwah ACY, Mactier RA. Antagonistic effect of nonsteroidal anti-inflammatory drugs on furosemide-induced diuresis in cardiac failure. BMJ. 1981;283:714.
12. Brown J, Dollery C, Valdes G. Interaction of nonsteroidal anti-inflammatory drugs with antihypertensive and diuretic agents. Am J Med. 1986;81(suppl 2B):43-57.
13. van den Ouweland FA, Gribnau FWJ, Meyboom RHB. Congestive heart failure due to nonsteroidal anti-inflammatory drugs in the elderly. Age Ageing. 1988;17:8-16.
14. Leufkens HGM. Pharmacy Records in Pharmacoepidemiology: Studies on Antiinflammatory and Antirheumatic Drugs [thesis]. Utrecht, the Netherlands: Utrecht University; 1990.
15. Heerdink ER. Compression and Clustering of Drug Use in the Elderly [thesis]. Utrecht, the Netherlands: Utrecht University; 1995.
16. Herings RM, Bakker A, Stricker BH, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health. 1992;46:136-140.
17. Anatomical Therapeutic Chemical (ATC) Classification Index. Oslo, Norway: World Health Organization Collaborating Centre for Drug Statistics Methodology; 1993.
18. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
19. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441-1446.
20. Carlson KJ, Lee DC-S, Goroll AH, et al. An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis. 1985;38:733-739.
21. Murray MD, Greene PK, Brater DC, Manatunga AK, Hall SD. Effects of flurbiprofen on renal function in patients with moderate renal insufficiency. Br J Clin Pharmacol. 1992;33:385-393.
22. Garrell S, Matarese RA. Renal effects of prostaglandins and clinical adverse effects of non-steroidal anti-inflammatory agents. Medicine (Baltimore). 1984;63:165-181.
23. Brater DC. Clinical aspects of renal prostaglandins and NSAID therapy. Semin Arthritis Rheum. 1988;17(3, suppl 2):17-22.
24. 1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology. 1979;77:215-222.
25. Wong F, Massie D, Hsu P, Dudley F. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology. 1993;104:369-376.
26. Armstrong PW, Moe GW. Medical advances in the treatment of congestive heart failure. Circulation. 1993;88:2941-2952.
27. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs: differences and similarities. N Engl J Med. 1991;324:1716-1725.
28. Heerdink ER, Leufkens HG, Koppedraijer C, Bakker A. Information on drug use in the elderly: a comparison of pharmacy, general practitioner and patient data. Pharm World Sci. 1995;17(10):20-24.